Farhat L. Khanim - Concepedia

Author

Farhat L. Khanim

Also Known As

F Khanim, F L Khanim, F. Khanim, F. L. Khanim, Farhat Khanim, Farhat L Khanim, Farhat L. Khanim, Farhat Latif Khanim, Farhat L Khanim, Farhat L. Khanim

106

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

University of Birmingham Keele University Institute of Cancer Research Queen Elizabeth Hospital Birmingham University of Liverpool

About

Farhat L. Khanim is an author at University of Birmingham specializing in medicine, cell biology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	23	1.5K
2	Health Sciences	8	8	704
3	Engineering	1	1	38
4	Natural Sciences	1	1	52
5	Public Health	1	1	35

Farhat L. Khanim

Publications

Citations

H-Index

Page 1

	Year	Citations
Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors Charlotte Bradbury, Farhat L. Khanim, Rachel Hayden, Leukemia Histone ModificationsChromatinHistone DeacetylasesHematological MalignancyChromatin Remodeling	2005	395
Clinical and Molecular Genetic Analysis of 19 Wolfram Syndrome Kindreds Demonstrating a Wide Spectrum of Mutations in WFS1 Carol Hardy, Farhat L. Khanim, Rosarelis Torres, The American Journal of Human Genetics Mendelian DisorderGenetic DisorderMedicineGeneticsPathology	1999	216
Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations Farhat L. Khanim, QY Yao, Gerald Niedobitek, Blood	1996	193
HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2 S P Lee, Wendy A. Thomas, R J Murray, Journal of Virology	1993	181
Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells Farhat L. Khanim, Lyndon Gommersall, Victoria Wood, Oncogene UrologyOncogenic AgentAltered Smrt LevelsMedicineProstate Cancer Cells	2004	140
PEP005, a selective small-molecule activator of protein kinase C, has potent antileukemic activity mediated via the delta isoform of PKC Peter Hampson, Hema Chahal, Farhat L. Khanim, Blood	2005	131
Metabolomic Profiling of Drug Responses in Acute Myeloid Leukaemia Cell Lines Stefano Tiziani, Alessia Lodi, Farhat L. Khanim, PLoS ONE Mixed-phenotype Acute LeukemiaMetabolomic ProfilingMetabolic RemodelingOxidative StressMyeloid Neoplasia	2009	117
The in Vitro Effects of Triiodothyronine on Epidermal Growth Factor-Induced Trophoblast Function Katherine J Barber, J. A. Franklyn, Christopher J. McCabe, The Journal of Clinical Endocrinology & Metabolism	2005	95
Metabolic plasticity in CLL: adaptation to the hypoxic niche Katarzyna M. Koczula, Christian Ludwig, Rachel Hayden, Leukemia	2015	94
Slug Regulates Integrin Expression and Cell Proliferation in Human Epidermal Keratinocytes Frances E. Turner, Simon Broad, Farhat L. Khanim, Journal of Biological Chemistry	2006	88

Page 1